查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552613

癌症醫學基因組學市場規模、佔有率和趨勢分析報告：按產品、按應用、按技術、按地區和細分市場預測，2024-2030

Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Diagnostics, Personalized Medicine), By Technology (Genome Sequencing, PCR), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

基因組學市場成長與癌症醫學趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球癌症治療基因組學市場預計將達到 509.7 億美元。

預計2024年至2030年複合年成長率將達16.0%。癌症盛行率的不斷上升，加上次世代定序在診斷和治療中的應用，預計將為市場帶來未來的成長機會。癌症發生率的增加將在未來幾年引發對具有成本效益和準確診斷的需求。

此外，對癌症分子表徵以確定治療標靶的個人化醫療的需求不斷成長，正在推動市場成長。同樣，基因組定序成本降低、醫療保健支出增加以及有效癌症診斷和治療方法的發展等因素也促進了基因組學在癌症護理中的潛在成長。

癌症醫學市場中的基因組學報告亮點

  • 就截至 2023 年的銷售佔有率而言，由於設備相關高成本，設備細分市場將佔整個市場的 54.8%。同時，耗材是基因組檢測中使用最廣泛的產品類別。
  • 由於基因組分析的外包活動增加，預計在預測期內，對次世代定序、PCR 以及其他癌症風險管理和基因檢測等服務的需求將會成長。進行基因測試的高昂成本以及人們對使用這些技術的相關好處的認知不斷增強，是對該細分市場產生重大影響的促進因素。
  • 由於對有效治療癌症的需求不斷增加以及製造商對新產品開發的生物製藥投資增加，預計藥物發現和開發領域在預測期內將呈現 18.5% 的有利複合年成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章癌症醫學基因組學市場的變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 癌症護理中的基因組市場分析工具
    • 波特的分析
    • PESTEL分析

第4章癌症醫學基因組學市場：按產品估計和趨勢分析

  • 細分儀表板
  • 癌症醫學基因組學市場：2023 年和 2030 年按產品分類的變異分析
  • 裝置
  • 消耗品
  • 服務

第5章癌症醫學中的基因組學市場：應用估計和趨勢分析

  • 細分儀表板
  • 癌症醫學基因組學市場：2023 年和 2030 年應用變化分析
  • 診斷
  • 個人化醫療
  • 藥物發現與開發
  • 調查

第6章癌症醫學基因組學市場：技術估計和趨勢分析

  • 細分儀表板
  • 癌症護理基因組學市場：2023 年和 2030 年技術變異分析
  • 基因組序列分析
  • PCR
  • 微陣列
  • 核酸萃取精製
  • 其他

第7章癌症醫學基因組學市場：區域估計和趨勢分析

  • 2023 年和 2030 年癌症醫學基因組學市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Agilent Technologies, Inc.,
    • F. Hoffmann-La Roche Ltd
    • Beckman Coulter, Inc.,
    • Illumina Inc.
    • Abbott
    • Cancer Genetics Inc.
    • Bio-Rad Laboratories
    • PacBio
    • GE Healthcare
    • Quest Diagnostics Incorporated
    • PerkinElmer
    • Luminex
簡介目錄
Product Code: 978-1-68038-717-9

Genomics In Cancer Care Market Growth & Trends:

The global genomics in cancer care market size is expected to reach USD 50.97 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 16.0% from 2024 to 2030. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

Genomics In Cancer Care Market Report Highlights:

  • Instrument segment dominated the overall market in terms of revenue share as of 2023 and accounted for 54.8% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
  • Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
  • Drug discovery and development segment is expected to show lucrative CAGR of 18.5% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Genomic in Cancer Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Genomic in Cancer Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Genomics in Cancer Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Genomics in Cancer Care Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Genomics in Cancer Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Genomics in Cancer Care Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Personalized Medicine
    • 5.4.1. Personalized Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Drug Discovery & Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Research
    • 5.6.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Genomics in Cancer Care Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Genomics in Cancer Care Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Genome Sequencing
    • 6.3.1. Genome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. PCR
    • 6.4.1. PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Microarrays
    • 6.5.1. Microarrays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Nucleic Acid Extraction & Purification
    • 6.6.1. Nucleic Acid Extraction & Purification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Other
    • 6.7.1. Other Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Genomics in Cancer Care Market: Regional Estimates & Trend Analysis

  • 7.1. Genomics in Cancer Care Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Agilent Technologies, Inc.,
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc.,
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Illumina Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Abbott
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Cancer Genetics Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. PacBio
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. GE Healthcare
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Quest Diagnostics Incorporated
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. PerkinElmer
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Luminex
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives